Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Are Dentists in Our Environment Correctly Following the Recommended Guidelines for Prophylaxis of Infective Endocarditis?

Anguita P, Anguita M, Castillo JC, Gámez P, Bonilla V, Herrera M.

Rev Esp Cardiol (Engl Ed). 2019 Jan;72(1):86-88. doi: 10.1016/j.rec.2018.04.029. Epub 2018 Jul 7. English, Spanish. No abstract available.

PMID:
30585156
2.

Prophylaxis of Infective Endocarditis in Dentistry: Analysis of the Situation After Almost a Decade of Clinical Practice Guidelines. Response.

Anguita P, Castillo JC, Herrera M, Anguita M.

Rev Esp Cardiol (Engl Ed). 2019 Jan;72(1):96. doi: 10.1016/j.rec.2018.07.018. Epub 2018 Oct 5. English, Spanish. No abstract available.

PMID:
30297277
3.

Behaviour of health professionals concerning the recommendations for prophylaxis for infectious endocarditis in our setting: Are the guidelines followed?

Anguita P, Castillo F, Gámez P, Carrasco F, Roldán R, Jurado B, Castillo JC, Martín E, Anguita M.

Rev Clin Esp. 2017 Mar;217(2):79-86. doi: 10.1016/j.rce.2016.10.005. Epub 2016 Dec 5. English, Spanish.

PMID:
27932198
4.

Optical analysis of CH3NH3Sn x Pb1-x I3 absorbers: a roadmap for perovskite-on-perovskite tandem solar cells.

Anaya M, Correa-Baena JP, Lozano G, Saliba M, Anguita P, Roose B, Abate A, Steiner U, Grätzel M, Calvo ME, Hagfeldt A, Míguez H.

J Mater Chem A Mater. 2016 Aug 7;4(29):11214-11221. Epub 2016 Jun 29.

5.

[Do we follow recommendations on infective endocarditis prophylaxis? Differences between the health professionals involved].

Castillo F, Castillo JC, Anguita P, Roldán R, Gámez P, Anguita M.

Aten Primaria. 2017 Mar;49(3):198-200. doi: 10.1016/j.aprim.2016.02.009. Epub 2016 Jun 23. Spanish. No abstract available.

6.

Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain.

Rubio-Terrés C, Cobo Reinoso J, Grau Cerrato S, Mensa Pueyo J, Salavert Lletí M, Toledo A, Anguita P, Rubio-Rodríguez D, Watt M, Gani R.

Eur J Clin Microbiol Infect Dis. 2015 Nov;34(11):2213-23. doi: 10.1007/s10096-015-2472-0. Epub 2015 Sep 25.

PMID:
26407619
7.

Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also Known as Clostridium Difficile-Associated Diarrhoea (CDAD) in Spain.

Cobo Reinoso J, Grau Cerrato S, Mensa Pueyo J, Salavert Lletí M, Toledo A, Anguita P, Rubio-Terrés C, Rubio-Rodríguez D.

Value Health. 2014 Nov;17(7):A674. doi: 10.1016/j.jval.2014.08.2501. Epub 2014 Oct 26. No abstract available.

8.

Per-species risk factors and predictors of invasive Candida infections in patients admitted to pediatric intensive care units: development of ERICAP scoring systems.

Jordan I, Balaguer M, López-Castilla JD, Belda S, Shuffelman C, Garcia-Teresa MA, Madurga P, Flores-Gonzalez JC, Anguita P, Aguilar L; ERICAP Study Group.

Pediatr Infect Dis J. 2014 Aug;33(8):e187-93. doi: 10.1097/INF.0000000000000274.

PMID:
24717965
9.

C. albicans, C. parapsilosis and C. tropicalis invasive infections in the PICU: clinical features, prognosis and mortality.

Jordán I, Hernandez L, Balaguer M, López-Castilla JD, Casanueva L, Shuffelman C, García-Teresa MA, de Carlos JC, Anguita P, Aguilar L; ERICAP study group.

Rev Esp Quimioter. 2014 Mar;27(1):56-62.

10.

Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinases.

Granda TG, Cebrián D, Martínez S, Anguita PV, López EC, Link W, Merino T, Pastor J, Serelde BG, Peregrina S, Palacios I, Albarran MI, Cebriá A, Lorenzo M, Alonso P, Fominaya J, López AR, Bischoff JR.

Invest New Drugs. 2013 Feb;31(1):66-76. doi: 10.1007/s10637-012-9835-5. Epub 2012 May 24.

PMID:
22623067
11.

[Images in cardiology. Cardiac amyloidosis].

Anguita P, García Touchard A, Castro Rd.

Rev Esp Cardiol. 2002 Jul;55(7):763. Spanish. No abstract available.

Supplemental Content

Loading ...
Support Center